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Spikenard, the dried roots of Nardostachys chinensis, contains sesquiterpenoids and is 
widely used as an herbal tranquilizer. We previously demonstrated that spikenard vapor 
showed a sedative effect when administered by inhalation, and we identified 
hydrocarbon sesquiterpenoids as active components. Here we investigated the other 
components that contribute to the effects of spikenard. Six oxygenated sesquiterpenoids, 
including aristolane- and guaiane-types, were isolated from an acetone extract of 
spikenard. We evaluated the sedative activities of these oxygenated compounds, using 
an inhalation administration method in caffeine-treated excitatory mouse model. We 
identified aristolen-1(10)-en-9-ol and patchouli alcohol as highly effective sedative 
components. These compounds inhibited locomotion in mice by approximately 60% at 
a dose of 300 µg/cage. In addition, aristolen-1(10)-en-9-ol prolonged 
pentobarbital-induced sleep to the same extent as 1 mg/kg diazepam. This effect 
completely disappeared with the administration of the GABAA-benzodiazepine receptor 
antagonist flumazenil (3 mg/kg), suggesting that the sedative effect of 
aristolen-1(10)-en-9-ol is expressed via the GABAergic system. Furthermore, different 
from diazepam, inhalation of aristolen-1(10)-en-9-ol for 1 h did not affect the motor 
coordination in the rota-rod test. In the present study, we identified active components 
and provided evidence, supporting the traditional sedative use of spikenard. Our 
research suggests that aristolen-1(10)-en-9-ol may be an effective aromatherapy, 
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Various stress conditions in daily life influence human health and may cause physical 
disorders, such as insomnia [1] and anxiety [2]. Benzodiazepines are widely used as 
sedative drugs but are associated with problematic side effects, including oversedation 
[3] or ataxia [4]. Therefore, as one of the complementary and alternative medicinal 
therapies, aromatherapy has recently attracted much attention for its ability to induce 
relaxation and to ameliorate stress. Spikenard, the dried underground part of 
Nardostachys chinensis Batalin, is a member of the family Valerianaceae found 
growing from Himalayan regions to southwest China. In traditional Chinese medicine, 
spikenard has been used as a gastrointestinal antispasmodic [5] and a traditional herbal 
tranquilizer [6]. Spikenard is also an essential ingredient in scented sachets used to 
improve insomnia. Our research focused on the characteristic fragrance of spikenard, 
the expression of the sedative effect by fragrance inhalation, and the identification of 
active ingredients. In our previous study, we investigated the sedative effect of 
spikenard hexane extract by inhalation administration in mice. We identified four 
hydrocarbon sesquiterpenoids from spikenard hexane extract as active compounds [7,8] 
and also revealed that its sedative effect due to administration by inhalation was 
expressed via olfactory stimulation and pulmonary absorption [9]. While preparing the 
spikenard essential oil to identify other volatile compounds, on GC–MS analysis, we 
detected several high intensity peaks in addition to the peaks for hydrocarbon 
sesquiterpenoids mentioned above (Fig. 1). The aim of the present study was to identify 
those compounds and to determine whether they contribute to the sedative effect of 
spikenard. The sedative activities of isolated compounds were evaluated in a 
caffeine-treated excitatory mouse model, using an inhalation administration method and 
an open-field test. The locomotor activity of these mice was more than doubled by 
caffeine administration [8]; therefore, the sedative activity of each compound could be 
easily detected. We also investigated the mechanism of the sedative action of the highly 
active compounds. To examine the involvement of the GABAergic system, we 
performed a pentobarbital sleep test with a GABAA-benzodiazepine receptor antagonist, 
flumazenil. We describe the characteristic compounds contained in spikenard and 





Six oxygenated sesquiterpenoids were isolated from the spikenard acetone extract in 
this study. Figure 1 shows the GC–FID chromatogram of the spikenard oil, and 
calculated retention index and the content ratio of each compound identified in the 
spikenard oil in the present study are indicated. Figure 2 shows the chemical structures 
of these compounds, of which six compounds were aristolane-type and two compounds 
were guaiane-type. Aristolen-1(10)-en-9-ol (13.6%) and patchouli alcohol (11.6%) were 
the main components of the spikenard oil, in addition to the volatile hydrocarbon 
calarene (13.5%). The sedative effects of the six oxygenated compounds were 
evaluated. 
To investigate whether the isolated oxygenated sesquiterpenoids contribute to the effect 
of spikenard, we assessed the total spontaneous locomotor activity of caffeine-treated 
mice in an open-field test. Figure 3 shows the total motor activity of mice exposed to 
various concentrations of sample solutions for 60 min. Diazepam, a positive control, 
inhibited the increase in locomotor activity of caffeine-treated mice dose-dependently, 
and the inhibition ratios at doses of 1 and 5 mg/kg were 60 % and 80%, respectively. 
Inhalation of the spikenard oil significantly sedated the caffeine-treated mice at a dose 
of 300 µg/cage (inhibition ratio, 41%). Of the isolated compounds, maaliol and 
β-ionone tended to show a sedative effect but not significantly. In contrast, both 
1(10)-aristolen-2-one and spathulenol showed significant sedative activity at a dose of 
300 µg/cage, with the inhibition ratios of 34% and 53%, respectively. Patchouli alcohol 
and aristolen-1(10)-en-9-ol had dose-dependent sedative effects, and the inhibition 
ratios at a dose of 300 µg/cage were 69% and 63%, respectively, and these effects were 
comparable to 1 mg/kg diazepam. 
Involvement of the GABAergic system in the sedative effects of patchouli alcohol and 
aristolen-1(10)-en-9-ol was investigated, using a pentobarbital sleep test (Fig. 4). Orally 
administered diazepam prolonged pentobarbital-induced sleeping times in a dose 
dependent manner. Compared with vehicle alone, diazepam significantly prolonged 
sleep duration at 1 and 5 mg/kg by 44 min (64% prolongation) and 107 min (299% 
prolongation), respectively. No effect was observed in the patchouli alcohol inhalation 
group; however, inhalation of aristolen-1(10)-en-9-ol (300 μg/cage) significantly 
prolonged sleeping time (47 min, 84% prolongation), and this effect was comparable to 
1 mg/kg diazepam. To investigate the involvement of the GABAergic system, mice 
were pretreated with flumazenil, a specific GABAA-benzodiazepine antagonist (Fig. 5). 
Pretreatment with flumazenil alone did not affect pentobarbital-induced sleep duration, 
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but the hypnotic activity of 1 mg/kg diazepam was inhibited by pretreatment with 3 
mg/kg flumazenil. In addition, the hypnotic effect of aristolen-1(10)-en-9-ol was 
completely antagonized by flumazenil.  
The influence of drug administration on the motor function was investigated, using a 
rota-rod test for 5 min. Figure 6 shows the endurance time (time to fall) of mice treated 
with diazepam or aristolen-1(10)-en-9-ol. In the diazepam group, a dose of 0.2 mg/kg 
did not disturb the motor coordination. However, doses of 1 and 5 mg/kg disturbed the 
motor coordination in a dose-dependent manner, with mean endurance times of 195 and 
37 sec, respectively. Half (4/8) of the mice in the 1 mg/kg diazepam group and all (8/8) 
of the mice in the 5 mg/kg group fell from the rod. Aristolen-1(10)-en-9-ol inhalation 





Spikenard has been widely used as a traditional herbal tranquilizer and in scented 
sachets to improve insomnia. Given that inhalation is a non-invasive administration 
route, we investigated the sedative effect of volatile compounds to assess the 
effectiveness of spikenard as aromatherapy. On GC analysis of the spikenard oil, we 
identified several high intensity peaks in addition to the peaks for the hydrocarbon 
sesquiterpenoids identified previously. These compounds were identified as oxidized 
sesquiterpenoids, including aristolane- and guaiane-type compounds. Open-field testing 
of caffeine-treated mice exposed to aristolen-1(10)-en-9-ol and patchouli alcohol 
demonstrated that these compounds have high sedative activity when administered by 
inhalation. In the pentobarbital-sleep test, to investigate the involvement of the 
GABAergic system, aristolen-1(10)-en-9-ol significantly prolonged the sleeping 
duration. Because we could not find an appropriate positive control drug with a known 
pharmacological mechanism using the same inhalation administration route, we used 
diazepam as a positive control. The administration of 5 mg/kg diazepam prolonged 
sleeping duration by 299% and markedly impaired the motor coordination, which is 
well known undesirable side effect of diazepam. Therefore, 5 mg/kg diazepam was 
strongly sedative. Diazepam (1 mg/kg) also prolonged the sleeping duration and mildly 
impaired the motor coordination. Therefore, 1 mg/kg diazepam was mildly sedative. 
The effect of aristolen-1(10)-en-9-ol was comparable to that of 1 mg/kg diazepam and 
was completely inhibited by 3 mg/kg flumazenil. Therefore, the sedative effect of 
aristolen-1(10)-en-9-ol appeared to involve agonism of the GABAA–benzodiazepine 
receptor. Rota-rod testing demonstrated that aristolen-1(10)-en-9-ol induced relaxation 
without the motor impairment or marked sedation. The sedative effect of patchouli 
alcohol appears to be mediated by a system other than the GABAergic system.  
A previous study found that the essential oil of Valeriana wallichi, which contains 
patchouli alcohol (40.2%), has an anti-depressant effect [10]. Furthermore, 
administration of V. wallichi essential oil increased cerebral serotonin and 
norepinephrine levels to a similar extent as imipramine. Imipramine also has a sedative 
effect; therefore, the mechanism of action of patchouli alcohol could involve the 
cerebral monoamine system. However, further research is needed to confirm this 
possible mechanism. In the present study, we identified active components of spikenard 
and provided evidence supporting the traditional sedative use of this compound. 
Although more studies are required to further elucidate the properties of 
aristolen-1(10)-en-9-ol, our research suggests that aristolen-1(10)-en-9-ol may be an 
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Materials and Methods 
 
General 
Triethyl citrate (purity > 99%, GC; Wako Pure Chemical Industries Ltd.), an odorless 
solvent, was used to dissolve isolated compounds or the spikenard oil. Caffeine (purity 
> 98.5%, TLC) and diazepam (purity > 98%, Ti) were purchased from Wako Pure 
Chemical Industries Ltd., flumazenil (purity > 99%, HPLC) was obtained from 
Sigma-Aldrich, Inc., and pentobarbital sodium salt (purity > 98%, N) was obtained from 
Tokyo Chemical Industry Co., Ltd.. Caffeine and pentobarbital were dissolved in 
physiological saline, and diazepam and flumazenil were suspended in a solution of 
dimethyl sulfoxide:Tween-80:physiological saline = 1:1:8. Column chromatography 
was performed using 60 N silica gel (40–50 μm, Kanto Chemical Co. Ltd.) and 
Cosmosil® 75C18-PREP (Nacalai Tesque Inc.). Preparative HPLC was performed using 
Cosmosil® 5C18-AR-2 (150 mm × 20 mm ID), and compounds were detected using UV 
(SPD-10A; Shimadzu Corporation) and a refractive index (RI-72, Showa Denko K.K.) 
detector. All chemicals and reagents were of the highest grade. 
 
Plant material 
Spikenard (lot number: 0080) was purchased from Mitsuboshi Pharmaceutical Co., Ltd. 
and identified by the authors. A voucher specimen of the plant material (No. 3735) was 
deposited in the Herbarium of Medicinal Plants Garden, Tokyo Metropolitan Institute of 
Public Health.  
 
Preparation of the essential oil 
Spikenard oil was isolated from the dried plant material by hydrodistillation for 3 h 
using a Clevenger-type apparatus according to previously reported methods [11].  
 
GC-FID and GC-MS analysis 
Quantitative analysis of the volatile component. GC-FID analyses were performed on a 
GC-2014 (Shimadzu Corporation) with a flame ionization detector and operating 
conditions were as follows: Column, Rtx®-5MS (Restek Corporation), 30 m × 0.25 mm, 
0.25 μm film thickness; column temperature, 60°C (1 min hold) = 180°C (∆2°C/min) = 
280°C (Δ10°C/min, 15 min hold); carrier gas, helium (39.2 cm/s); injector, 230°C; 
detector, 300°C; injection volume, 1 μL (split less).  
Qualitative analysis of the volatile component. GC-MS analyses were performed on a 
GC-2010/GCMS-QP2010 Plus (Shimadzu Corporation), with operating conditions as 
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follows: Column and column temperature as above; carrier gas, helium (38.3 cm/s); 
injector, 230°C; interface, 250°C; ion source, 200°C; injection volume, 1 μL (split less). 
MS was operated in the EI mode at an ionization voltage of 70 eV over an m/z range 
from 30 to 400 amu. Retention indices were determined relative to the retention times of 
a series of n-alkane standards (10–20 carbons; GL Sciences Inc.), measured under the 
chromatographic conditions described above. 
 
Extraction and isolation 
Spikenard (150 g) was subjected to acetone extraction three times at room temperature. 
The acetone extract was concentrated under reduced pressure and silica gel column 
chromatography (25 × 5 cm) was performed using the concentrate (12 g). The column 
was first eluted with n-hexane to yield fractions 1–5, and then eluted with 
n-hexane–EtOAc mixtures with increasing polarity (40:1 to 2:1) to yield fractions 6–12. 
Fraction 7 (159.3 mg) was purified by preparative HPLC [solvent, CH3CN:H2O (70:30); 
flow rate, 6.0 mL/min], which yielded β-ionone (5.66 mg). Fraction 8 (268.5 mg) was 
applied to an ODS column (14 × 2.6 cm) and eluted with CH3CN:H2O (6:4 to 10:0) to 
yield fractions 1–5, while further preparative HPLC of the fraction 8–3 (177.2 mg) 
[solvent, CH3CN:H2O (82:18); flow rate, 6.0 mL/min] yielded patchouli alcohol (154.3 
mg). Fraction 10 (978.3 mg) was chromatographed over ODS using the same conditions 
described above. Seven fractions were obtained, and further preparative HPLC of 
fraction 10-2 [734.7 mg; solvent, CH3CN:H2O (70:30); flow rate, 6.0 mL/min] yielded 
1(10)-aristolen-2-one (62.8 mg) as fraction 10-2-1. Fraction 10-2-2 was further purified 
by preparative HPLC [solvent, CH3CN:H2O (73:27); flow rate, 6.0 mL/min] to yield 
spathulenol (60.5 mg), aristolen-1(10)-en-9-ol (244.3 mg), and maaliol (78.2 mg). The 
purities of isolated compounds were over 98% (GC-FID). 
 
Animals 
Four-week-old male ddY mice were purchased from Japan SLC, Inc.. Prior to 
experimentation, mice were acclimatized for 1 week to a temperature of 25°C ± 2°C, 
humidity of 50% ± 10%, and a 12-h light/12-h dark cycle. All behavioral observations 
were recorded between 10:00 and 15:00 h. Experiments were performed in accordance 
with the Kitasato University guidelines for animal care, handling, and termination, 
which are in line with the international and Japanese guidelines for animal care and 





The fragrance components were dissolved in triethyl citrate (30 µL total) for 
experiments. A thick paper disk (2.5 × 3.0 cm, 1 mm in thickness) was permeated with 
sample solution and placed on a hotplate diffuser (approximately 70°C) in the upper 
portion of the cage. The cylindrical cage was made of transparent polycarbonate (22 cm 
in height, 25 cm in diameter) and covered with vinyl film so the vapor from the sample 
solution could pervade the cage. A mouse treated with caffeine or pentobarbital was 
placed in the center of the cage 30 min after charging the solution. The fragrance 
inhalation dose was set to 30 or 300 µg/cage, on the basis of previous studies [7]. 
 
Caffeine administration test 
Caffeine was orally administered to mice at a dose of 20 mg/kg. Each mouse was placed 
in a cage filled with vapor from the sample solution 30 min after administration, and the 
locomotor activity was measured for another 60 min using an open-field test. As a 
positive control, diazepam was administered at doses of 0.2, 1, and 5 mg/kg (po) 30 min 
before caffeine peroral administration. The test was performed according to the method 
described by Kobayashi et al. [12] in the same cylindrical cages equipped with a passive 
infrared sensor (PYS-001; Muromachi Kikai Co., Ltd.). Spontaneous motor activity was 
recorded using a passive infrared sensor detection system (SUPERMEX; Muromachi 
Kikai Co., Ltd.) and analyzed using CompACT AMS software (Muromachi Kikai Co., 
Ltd.). 
 
Pentobarbital sleep test 
Mice were administered pentobarbital (ip) at a dose of 30 mg/kg and immediately 
placed in a cage filled with vapor of the sample solution (300 μg/cage). Sleep duration 
was defined as the time difference between loss and recovery of the righting reflex. As a 
positive control, diazepam at a dose of 0.2, 1, and 5 mg/kg (po) was administered 30 
min before pentobarbital injection. Flumazenil, a specific GABAA-benzodiazepine 




A rota-rod treadmill (MK-600; Muromachi Kikai Co., Ltd) was used in this study. To 
adapt to the rota-rod, one day before the test, mice were placed on the rod rotating at 28 
rpm for 5 min each hour three times. On the test day, one more episode of training was 
performed and mice that failed to stay on the rod were excluded from the experiment. 
The duration, up to 5 min, that mice could remain on the rota-rod was recorded after 60 
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min of sample inhalation or 30 min after diazepam administration. 
 
Statistical analysis 
All results are expressed as the mean ± standard deviation (SD). The data were analyzed 
using the one-way analysis of variance (ANOVA) followed by Tukey’s multiple 
comparison test. For the flumazenil treatment experiment (Fig. 5), Student’s t-test was 
used to compare the values from the two groups. All statistical analyses were performed 
using Prism 5 (GraphPad SoftwaInc.), and P values < 0.05 were considered to be 
significant. 
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Fig. 1 A GC chromatogram of the GC–FID analysis of the spikenard oil. The retention 
index (RI) and percent composition of the 10 main peaks are indicated below. 1: 
β-Maaliene, RI 1405, 3.1%; 2: Aristolene, RI 1413, 2.1%; 3: Calarene, RI 1428, 13.5%; 
4: Valerena-4,7(11)-diene, RI 1459, 1.9%; 5: β-Ionone, RI 1485, 3.6%; 6: Maaliol, RI 
1562, 6.4%; 7: Spathulenol, RI 1573, 5.6%; 8: Patchouli alcohol, RI 1650, 11.6%; 9: 
Aristolen-1(10)-en-9-ol, RI 1661, 13.6%; and 10: 1(10)-Aristolen-2-one, RI 1754, 
4.4%. 
 
Fig. 2 Chemical structures of sesquiterpenoids as numbered in the GC chromatogram in 
Fig. 1.  
 
Fig. 3 Total motor activity of caffeine-treated mice exposed to the vapor of oxidized 
sesquiterpenoids (0, 30, and 300 µg/cage). Results represent mean ± SD of values for 
each group (n = 8). *P < 0.05, **P < 0.01 vs. vehicle group; one-way ANOVA followed 
by Tukey’s test. 
 
Fig. 4 Effects of vaporized patchouli alcohol (PA) and aristolen-1(10)-en-9-ol 
(ARI-9-ol) on sleep duration in a pentobarbital sleep test. Results represent mean ± SD 
of values for each group (n = 8). **P < 0.01 vs. vehicle group; one way ANOVA 
followed by Tukey’s test. 
 
Fig. 5 Effect of flumazenil (FLU) on sleep duration in mice treated with diazepam (po) 
and aristolen-1(10)-en-9-ol (ARI-9-ol) (inhalation). Results represent mean ± SD of 
values for each group (n = 8). **P < 0.01 vs. vehicle group (Student’s t-test), ##P < 0.01 
for FLU treatment vs. treatment without FLU (Student’s t-test). NS, not significant. 
 
Fig. 6 Effect of aristolen-1(10)-en-9-ol (ARI-9-ol) on the rotating rod performance of 
mice. Each bar represents mean ± SD of the endurance time during the 5 min rota-rod 
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